Search results
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 1 day agoModerna price target raised at Oppenheimer after RSV vaccine approval
COVID cases rising in L.A. County and California as new subvariants make mark
Los Angeles Times· 20 hours agoCalifornia’s COVID numbers are on the rise thanks, in part, to new subvariants, suggesting an...
Connectus Wealth LLC Purchases 2,016 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day agoConnectus Wealth LLC increased its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 90.8% during the fourth quarter, according to the company in its most ...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 3 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
3 Reasons to Buy Moderna Stock | The Motley Fool
The Motley Fool· 5 days agoAlthough Moderna (MRNA -2.38%) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Is Moderna just...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance· 2 days agoModerna (MRNA) is on its way to getting a third mRNA-based vaccine approved by the FDA if the...
State of Tennessee Treasury Department Boosts Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day agoState of Tennessee Treasury Department increased its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 27.5% in the fourth quarter, according to its most recent Form ...
Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs
Barrons.com· 3 days agoThe results could to upend the flu market if they withstand scrutiny from regulators. More than half...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...